1-2

Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country. Merck was also the first Merck Group Company to go public in the year 1981. The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd.

Post : Drug Safety Associate

Sri Krishna Pharmaceuticals Ltd, established in 1974, started life as a pioneer in the bulk manufacture of acetaminophen (Paracetamol) for the domestic Indian market. Today, the company is a vertically integrated bulk manufacturer of multiple first-line-of-defence APIs, PFIs and finished dosage drugs. Paracetamol is still very important to the company and the company remains one of the largest manufacturers in the world.

Post : Trainee to Officer

CORONA Remedies Private Limited is fastest growing Pharmaceutical organization based from Ahmedabad (India). We offer finest working culture to professionals. Our Care for Coronets is industry known.

Post : Research Associate / Senior Research Associate in FORMULATION & DEVELOPMENT Department

RAKS Pharma was conceptualized to become a significant API player so as to manufacture & supply APIs & Drugs Intermediate to Regulated & Non-Regulated Market from its present manufacturing site in Visakhapatnam (Andhra Pradesh), and upcoming unit in Dahej (Gujarat) India.

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.  Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

Stallion Laboratories incorporated in 1988 as an integrated private sector Pharmaceutical Formulation Manufacturer, has acquired an unmatched record of managing niche product in formulations with a WHO GMP approved production fatality and GLP qualified stringent quality control. The path of success lies in its belief of creativity and no negotiation with the quality of work. Stallion Laboratories is coming up with Unit II which is proposed to be UK-MHRA, EU GMP & PICS approved plant. With its approval. Stallion aims to enter regulated markets.

Intas is one of the leading multinational pharmaceutical formulation development manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happinessand hope.

Post : Officer / Executive

Medreich is a fully integrated pharmaceutical company with an established presence across the globe. The company is involved in the CMO & CDMO business of pharmaceutical preparations in various dosage forms catering to diverse Therapeutic categories.  Medreich has an advanced state of the art Research and Development centre with proven scientific competence to develop formulations as Patent Non-infringing and Niche generics in differentiated dosage form for global regulated markets.